(-0.34%) 5 196.25 points
(-0.13%) 38 975 points
(-0.48%) 18 111 points
(-1.33%) $77.34
(2.99%) $2.27
(0.03%) $2 324.80
(0.17%) $27.59
(-0.82%) $980.30
(0.15%) $0.931
(0.35%) $10.94
(0.25%) $0.801
(0.75%) $92.13
-5.45% £ 2.08
Live Chart Being Loaded With Signals
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East...
Stats | |
---|---|
Volumen de hoy | 59 676.00 |
Volumen promedio | 498 530 |
Capitalización de mercado | 4.94M |
EPS | £0 ( 2023-11-21 ) |
Próxima fecha de ganancias | ( £0 ) 2024-08-01 |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | -2.08 |
ATR14 | £0.204 (11.66%) |
Volumen Correlación
Omega Diagnostics Group Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Omega Diagnostics Group Correlación - Moneda/Commodity
Omega Diagnostics Group Finanzas
Annual | 2022 |
Ingresos: | £7.55M |
Beneficio Bruto: | £3.55M (46.98 %) |
EPS: | £-0.0166 |
FY | 2022 |
Ingresos: | £7.55M |
Beneficio Bruto: | £3.55M (46.98 %) |
EPS: | £-0.0166 |
FY | 2022 |
Ingresos: | £8.54M |
Beneficio Bruto: | £5.10M (59.75 %) |
EPS: | £-0.00770 |
FY | 2021 |
Ingresos: | £8.73M |
Beneficio Bruto: | £4.46M (51.04 %) |
EPS: | £-0.0164 |
Financial Reports:
No articles found.
Omega Diagnostics Group
Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company operates through two segments, Health and Nutrition, and Global Health and Other. The Health and Nutrition segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Global Health and Other segment engages in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment offers VISITECT CD4, an advanced disease rapid test, which is used to treat patients with HIV; and AbC-19, a COVID-19 antibody testing kit, as well as COVID-19 antigen and antibody testing solutions. The company offers its products to hospitals, clinics, laboratories, and healthcare practitioners through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico